When do I order procalcitonin (PCT) in patients with suspected infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Order procalcitonin (PCT) primarily for patients with suspected sepsis, lower respiratory tract infections like pneumonia, or when trying to differentiate between bacterial and viral infections, as it can help guide antibiotic initiation and discontinuation, especially in emergency departments and intensive care settings 1. When evaluating patients with suspected infections, PCT testing can be valuable in determining the need for antibiotics. The test is most useful in settings where rapid decisions about antibiotic therapy are crucial.

  • PCT levels above 0.5 ng/mL suggest bacterial infection, while levels below 0.25 ng/mL make bacterial infection less likely 1.
  • Serial PCT measurements can help guide antibiotic discontinuation, as declining levels (especially drops of >80% from peak) suggest resolving infection 1.
  • PCT has limitations, including elevation in non-infectious conditions like trauma, surgery, and certain cancers, and may not rise significantly with localized infections or infections caused by atypical pathogens 1.
  • A recent systematic review and meta-analysis demonstrated that PCT-guided antibiotic treatment in ICU patients with infection and sepsis patients resulted in improved survival and lower antibiotic treatment duration 1.
  • The European Society of Clinical Microbiology and Infectious Diseases guidelines suggest the use of procalcitonin in the ED to guide the initiation of antibiotics for patients with suspected LRTI who are likely to be admitted to the hospital, with a weak recommendation and moderate certainty of evidence 1.
  • PCT should complement clinical judgment rather than replace it, as no single biomarker is perfect for diagnosing infections 1.
  • Using PCT appropriately can reduce unnecessary antibiotic use, decrease antibiotic duration, and potentially improve patient outcomes while combating antimicrobial resistance 1.

From the Research

When to Order Procalcitonin

Procalcitonin (PCT) is a biomarker used to guide antibiotic therapy in patients with suspected infections. The decision to order PCT should be based on the following considerations:

  • Clinical presentation: PCT is useful in differentiating bacterial infections from non-infectious causes of systemic inflammatory response syndrome (SIRS) 2.
  • Patient population: PCT can be used in various patient populations, including those with acute respiratory tract infections, sepsis, and septic shock 3, 4, 5.
  • Antibiotic therapy: PCT can help guide the initiation and duration of antibiotic therapy, reducing the risk of antibiotic overuse and resistance 3, 4, 5.

Indications for Procalcitonin Measurement

The following are indications for measuring PCT:

  • Suspected bacterial infection: PCT can help diagnose bacterial infections and guide antibiotic therapy 6, 3, 4.
  • Sepsis or septic shock: PCT can help differentiate sepsis from non-infectious causes of SIRS and guide antibiotic therapy 2, 5.
  • Acute respiratory tract infections: PCT can help guide antibiotic therapy in patients with acute respiratory tract infections 3, 4.

Interpretation of Procalcitonin Results

When interpreting PCT results, consider the following:

  • Threshold values: Higher thresholds for diagnosing infection or de-escalating therapy should be considered in special populations, such as those with renal dysfunction or immunosuppression 6.
  • Clinical context: PCT results should be considered in the context of clinical presentation, medical history, and other laboratory results 6, 2.
  • Serial measurements: Serial PCT measurements can help guide antibiotic therapy and reduce antibiotic exposure 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Procalcitonin: present and future.

Irish journal of medical science, 2015

Research

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Evidence-based child health : a Cochrane review journal, 2013

Research

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

American journal of respiratory and critical care medicine, 2008

Research

Procalcitonin in special patient populations: Guidance for antimicrobial therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.